SHIVOM is a decentralized block chain platform where people can get their genome sequenced and stored hence enabling the establishment of a highly scalable and fully integrated health care vertical.
PROS:
CONS:
SUGGESTIONS:
24-Apr: I have no plans to participate in Project Shivom.
Judging from the negative point I have raised, the project does not sound of investment quality. However, the overall concept of the platform is unique, and the venture could face a revisit if the inefficiencies get the adequate solutions.
In conclusion for this stage, there is not enough information regarding the Shivom project. There is little information on the part of their operations and supposed partnerships or advisors. As such, I would not recommend on putting your investment in such a project.
Strengths: signed partnerships; very strong team and world-renowned advisors. Thorough market research and clear vision of the market, business model is presented in detailed way.
Weaknesses: no financial plan/projection, no competitor analysis, no marketing plan. The product is technically advanced, this may require additional funds.
Having researched the Shivom proposition, it is difficult not to like what this project is setting out to achieve. If the team do succeed in their vision, the impact will be far-reaching and positive for everyone all round.
Clinical researchers get access to larger as well as much more representative genomic data sets allowing them to pursue their research further; those who provide that data are able to both protect and monetise that data however they see fit; medical professionals will be better positioned to provide more personalised healthcare; and academic researchers will be able to expand their research remits.
Whilst it is difficult to judge the overall potential for success for this project – or any blockchain-based startup project, for that matter – the general early signs appear quite good: there are clear indications of engaged interest from the general public as well as private seed investor investors which should mean that the project team manage to raise the funds necessary to proceed with the proposition. After that, the project’s chances should simply boil down to its ability to execute well.